Validation and characterization of a novel method for selective vagal deafferentation of the gut
Triple-Action Structure With Added Glucagon Retatrutide is a triple-action therapy that, like Lillys Mounjaro and Zepbound drugs, targets glucagon-like peptide-1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP, while also acting on the glucagon receptor
As the population of older adults grows and the wider clinical acceptance of therapies increases, the adoption rate is speeding up
(Listen as Jim LaValle, RPh, CCN, explains the factors that contribute to insulin resistance, how to measure and monitor blood sugar, and the habits we can adopt to manage blood sugar effectively at Breaking Insulin Resistance: Your Guide to Blood-Sugar Mastery.) When people eat [high-glycemic] foods that spike their insulin levels, their blood sugar rapidly rises and falls, explains Monique Class, MS, APRNBC, a clinical nurse specialist in holistic health in Stamford, Conn
verify current information from official sources before travel
Understanding Gastroparesis How GLP-1 Inhibitors Impact Gastroparesis Temporary vs